Ken Hawkins, a 77-year-old retiree from Southern Oregon, traveled to Oregon Health & Science University to participate in a clinical trial testing a technique that blocks the production of a protein that causes a life-threatening condition known as transthyretin amyloidosis. (OHSU/Christine Torres Hicks)
